Abstract
Immunotherapy has been a trusted therapy for centuries to eliminate infectious diseases. However, the successful immunotherapy depends on several factors such as nature of pathogen, vaccine delivery system, route of administration, and immune system of the host. With the advances in nanotechnology, immunotherapy is now targeting different challenging disorders including cancer as well as infectious diseases. Along with the evolution of several adjuvants to enhance immune response to vaccines, nanotechnology plays an important role by acting as self-adjuvant in form of particles.
Cite
CITATION STYLE
D’souza, M. J., Tawde, S. A., Akalkotkar, A., Chablani, L., D’souza, M., & Chiriva-Internati, M. (2014). Nanotechnology in vaccine delivery. In Molecular Vaccines: From Prophylaxis to Therapy - Volume 2 (pp. 727–741). Springer International Publishing. https://doi.org/10.1007/978-3-319-00978-0_19
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
